Zdrowie i gospodarka · 04/10/2017
FDA Requests Public Comment on Proposed Labeling Requirements for Prescription Drugs and Biological Products
The Food and Drug Administration is seeking public input on proposed labeling requirements for human prescription drugs and biological products, specifically focusing on pregnancy and lactation labeling, as mandated by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →